SEC Tracker
Get the app

Adaptin Bio APTN

Adaptin Bio: securities offering (amended)

Form
S-1/A
Filed
Importance
Routine
Document
S-1/A

Not explained yet; the original is on EDGAR.

Securities offering (amended)

View on EDGAR

Open in the app

Get an email when Adaptin Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Artelo Biosciences ARTL public float $9M, Jun 30, 2025
  2. Bioxytran BIXT public float $9M, Jun 30, 2025
  3. Raphael Pharmaceutical RAPH public float $9M, Jun 30, 2025
  4. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025
  5. TherapeuticsMD TXMD public float $9M, Jun 30, 2025